ABVC BioPharma, Inc. (ABVC)
0.83
+0.03
(+4.31%)
USD |
NASDAQ |
Aug 28, 16:00
0.858
+0.03
(+3.37%)
Pre-Market: 08:34
ABVC BioPharma Cash and Short Term Investments (Quarterly) : 0.0944M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0944M |
| March 31, 2026 | 0.2025M |
| December 31, 2025 | 1.391M |
| September 30, 2025 | 0.9191M |
| June 30, 2025 | 1.142M |
| March 31, 2025 | 0.8246M |
| December 31, 2024 | 0.9286M |
| September 30, 2024 | 0.8407M |
| June 30, 2024 | 0.8185M |
| March 31, 2024 | 0.7349M |
| December 31, 2023 | 0.7961M |
| September 30, 2023 | 1.190M |
| June 30, 2023 | 0.819M |
| March 31, 2023 | 1.870M |
| December 31, 2022 | 1.468M |
| September 30, 2022 | 2.048M |
| June 30, 2022 | 3.682M |
| March 31, 2022 | 3.528M |
| December 31, 2021 | |
| September 30, 2021 | 4.561M |
| June 30, 2021 | 1.657M |
| March 31, 2021 | 3.333M |
| December 31, 2020 | 5.001M |
| September 30, 2020 | 0.1519M |
| June 30, 2020 | 0.4064M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1398M |
| December 31, 2019 | 0.1604M |
| September 30, 2019 | 1.052M |
| June 30, 2019 | 0.5564M |
| March 31, 2019 | 0.9974M |
| December 31, 2018 | 0.2428M |
| September 30, 2018 | 0.0044M |
| June 30, 2018 | 0.0574M |
| March 31, 2018 | 0.0057M |
| December 31, 2017 | 0.0933M |
| September 30, 2017 | 0.2049M |
| June 30, 2017 | 0.0081M |
| December 31, 2016 | 0.0186M |
| September 30, 2016 | 0.1735M |
| June 30, 2016 | 0.0849M |
| March 31, 2016 | 0.8726M |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.0034M |
| June 30, 2015 | 0.0023M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.0005M |
| March 31, 2014 | 0.0006M |
| December 31, 2013 | 0.0006M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 38.41M |
| Perspective Therapeutics, Inc. | 236.88M |
| MiMedx Group, Inc. | 135.84M |
| Abbott Laboratories | 5.603B |
| AngioDynamics, Inc. | 53.86M |